APO Research
Talk to an analyst

APO RESEARCH · REPORT

Whole Blood, Plasma and Serum Viscometers

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Whole Blood, Plasma and Serum Viscometers Market Outlook and Growth Opportunities 2026

4 July 2026195 pages

Choose your research edition.

Industry ResearchWhole Blood, Plasma and Serum Viscometers Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Whole Blood, Plasma and Serum Viscometers Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Whole Blood, Plasma and Serum Viscometers Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Whole Blood, Plasma and Serum Viscometers Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Whole Blood, Plasma and Serum Viscometers Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Whole Blood, Plasma and Serum Viscometers market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Whole Blood, Plasma and Serum Viscometers is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Whole Blood, Plasma and Serum Viscometers is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Whole Blood, Plasma and Serum Viscometers is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Whole Blood, Plasma and Serum Viscometers market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Whole Blood, Plasma and Serum Viscometers market include ​BioFluid Technology, AMETEK Brookfield, Anton Paar, Benson Viscometers, Health Onvector, LAMY RHEOLOGY, LAUDA, RheoSense and Thermo Fisher Scientific, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Whole Blood, Plasma and Serum Viscometers market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Whole Blood, Plasma and Serum Viscometers and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Whole Blood, Plasma and Serum Viscometers sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Whole Blood, Plasma and Serum Viscometers market size, projected growth trends, production technologies, key applications, and end-use industries.

Whole Blood, Plasma and Serum Viscometers Segment by Company

​BioFluid Technology

AMETEK Brookfield

Anton Paar

Benson Viscometers

Health Onvector

LAMY RHEOLOGY

LAUDA

RheoSense

Thermo Fisher Scientific

Whole Blood, Plasma and Serum Viscometers Segment by Type

Rotational Viscometer

Capillary Viscometer

Whole Blood, Plasma and Serum Viscometers Segment by Application

Clinic

Hospital

Laboratory

Whole Blood, Plasma and Serum Viscometers Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Whole Blood, Plasma and Serum Viscometers status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Whole Blood, Plasma and Serum Viscometers market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Whole Blood, Plasma and Serum Viscometers significant trends, drivers, influence factors in global and regions.

6. To analyze Whole Blood, Plasma and Serum Viscometers competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Whole Blood, Plasma and Serum Viscometers market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Whole Blood, Plasma and Serum Viscometers and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Whole Blood, Plasma and Serum Viscometers.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Whole Blood, Plasma and Serum Viscometers market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Whole Blood, Plasma and Serum Viscometers industry.

Chapter 3: Detailed analysis of Whole Blood, Plasma and Serum Viscometers manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Whole Blood, Plasma and Serum Viscometers in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Whole Blood, Plasma and Serum Viscometers in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Whole Blood, Plasma and Serum Viscometers Industry Trends Table 2. Whole Blood, Plasma and Serum Viscometers Industry Drivers Table 3. Whole Blood, Plasma and Serum Viscometers Industry Opportunities and Challenges Table 4. Whole Blood, Plasma and Serum Viscometers Industry Restraints Table 5. Global Whole Blood, Plasma and Serum Viscometers Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Whole Blood, Plasma and Serum Viscometers Revenue Share by Company (2021-2026) Table 7. Global Whole Blood, Plasma and Serum Viscometers Sales Volume by Company (k units) & (2021-2026) Table 8. Global Whole Blood, Plasma and Serum Viscometers Sales Volume Share by Company (2021-2026) Table 9. Global Whole Blood, Plasma and Serum Viscometers Average Price (USD/unit) of Company (2021-2026) Table 10. Global Whole Blood, Plasma and Serum Viscometers Company Ranking, (2024-2026) & (USD Million) Table 11. Global Whole Blood, Plasma and Serum Viscometers Key Company Manufacturing Base & Headquarters Table 12. Global Whole Blood, Plasma and Serum Viscometers Company, Product Type & Application Table 13. Global Whole Blood, Plasma and Serum Viscometers Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Whole Blood, Plasma and Serum Viscometers by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Rotational Viscometer Table 18. Significant Companies of Capillary Viscometer Table 19. Global Whole Blood, Plasma and Serum Viscometers Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Whole Blood, Plasma and Serum Viscometers Sales Volume by Type (2021-2026) & (k units) Table 21. Global Whole Blood, Plasma and Serum Viscometers Sales Volume by Type (2027-2032) & (k units) Table 22. Global Whole Blood, Plasma and Serum Viscometers Sales Volume Share by Type (2021-2026) Table 23. Global Whole Blood, Plasma and Serum Viscometers Sales Volume Share by Type (2027-2032) Table 24. Global Whole Blood, Plasma and Serum Viscometers Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Whole Blood, Plasma and Serum Viscometers Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Whole Blood, Plasma and Serum Viscometers Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Whole Blood, Plasma and Serum Viscometers Sales Value Share by Type (2021-2026) Table 28. Global Whole Blood, Plasma and Serum Viscometers Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Clinic Table 30. Significant Companies of Hospital Table 31. Significant Companies of Laboratory Table 32. Global Whole Blood, Plasma and Serum Viscometers Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Whole Blood, Plasma and Serum Viscometers Sales Volume by Application (2021-2026) & (k units) Table 34. Global Whole Blood, Plasma and Serum Viscometers Sales Volume by Application (2027-2032) & (k units) Table 35. Global Whole Blood, Plasma and Serum Viscometers Sales Volume Share by Application (2021-2026) Table 36. Global Whole Blood, Plasma and Serum Viscometers Sales Volume Share by Application (2027-2032) Table 37. Global Whole Blood, Plasma and Serum Viscometers Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Whole Blood, Plasma and Serum Viscometers Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Whole Blood, Plasma and Serum Viscometers Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Whole Blood, Plasma and Serum Viscometers Sales Value Share by Application (2021-2026) Table 41. Global Whole Blood, Plasma and Serum Viscometers Sales Value Share by Application (2027-2032) Table 42. Global Whole Blood, Plasma and Serum Viscometers Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Whole Blood, Plasma and Serum Viscometers Sales by Region (2021-2026) & (k units) Table 44. Global Whole Blood, Plasma and Serum Viscometers Sales Market Share by Region (2021-2026) Table 45. Global Whole Blood, Plasma and Serum Viscometers Sales by Region (2027-2032) & (k units) Table 46. Global Whole Blood, Plasma and Serum Viscometers Sales Market Share by Region (2027-2032) Table 47. Global Whole Blood, Plasma and Serum Viscometers Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Whole Blood, Plasma and Serum Viscometers Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Whole Blood, Plasma and Serum Viscometers Sales Value Share by Region (2021-2026) Table 50. Global Whole Blood, Plasma and Serum Viscometers Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Whole Blood, Plasma and Serum Viscometers Sales Value Share by Region (2027-2032) Table 52. Global Whole Blood, Plasma and Serum Viscometers Market Average Price (USD/unit) by Region (2021-2026) Table 53. Global Whole Blood, Plasma and Serum Viscometers Market Average Price (USD/unit) by Region (2027-2032) Table 54. Global Whole Blood, Plasma and Serum Viscometers Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Global Whole Blood, Plasma and Serum Viscometers Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Whole Blood, Plasma and Serum Viscometers Sales by Country (2021-2026) & (k units) Table 57. Global Whole Blood, Plasma and Serum Viscometers Sales Market Share by Country (2021-2026) Table 58. Global Whole Blood, Plasma and Serum Viscometers Sales by Country (2027-2032) & (k units) Table 59. Global Whole Blood, Plasma and Serum Viscometers Sales Market Share by Country (2027-2032) Table 60. Global Whole Blood, Plasma and Serum Viscometers Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Whole Blood, Plasma and Serum Viscometers Sales Value Market Share by Country (2021-2026) Table 62. Global Whole Blood, Plasma and Serum Viscometers Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Whole Blood, Plasma and Serum Viscometers Sales Value Market Share by Country (2027-2032) Table 64. ​BioFluid Technology Company Information Table 65. ​BioFluid Technology Business Overview Table 66. ​BioFluid Technology Whole Blood, Plasma and Serum Viscometers Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 67. ​BioFluid Technology Whole Blood, Plasma and Serum Viscometers Product Portfolio Table 68. ​BioFluid Technology Recent Development Table 69. AMETEK Brookfield Company Information Table 70. AMETEK Brookfield Business Overview Table 71. AMETEK Brookfield Whole Blood, Plasma and Serum Viscometers Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 72. AMETEK Brookfield Whole Blood, Plasma and Serum Viscometers Product Portfolio Table 73. AMETEK Brookfield Recent Development Table 74. Anton Paar Company Information Table 75. Anton Paar Business Overview Table 76. Anton Paar Whole Blood, Plasma and Serum Viscometers Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 77. Anton Paar Whole Blood, Plasma and Serum Viscometers Product Portfolio Table 78. Anton Paar Recent Development Table 79. Benson Viscometers Company Information Table 80. Benson Viscometers Business Overview Table 81. Benson Viscometers Whole Blood, Plasma and Serum Viscometers Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 82. Benson Viscometers Whole Blood, Plasma and Serum Viscometers Product Portfolio Table 83. Benson Viscometers Recent Development Table 84. Health Onvector Company Information Table 85. Health Onvector Business Overview Table 86. Health Onvector Whole Blood, Plasma and Serum Viscometers Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 87. Health Onvector Whole Blood, Plasma and Serum Viscometers Product Portfolio Table 88. Health Onvector Recent Development Table 89. LAMY RHEOLOGY Company Information Table 90. LAMY RHEOLOGY Business Overview Table 91. LAMY RHEOLOGY Whole Blood, Plasma and Serum Viscometers Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. LAMY RHEOLOGY Whole Blood, Plasma and Serum Viscometers Product Portfolio Table 93. LAMY RHEOLOGY Recent Development Table 94. LAUDA Company Information Table 95. LAUDA Business Overview Table 96. LAUDA Whole Blood, Plasma and Serum Viscometers Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. LAUDA Whole Blood, Plasma and Serum Viscometers Product Portfolio Table 98. LAUDA Recent Development Table 99. RheoSense Company Information Table 100. RheoSense Business Overview Table 101. RheoSense Whole Blood, Plasma and Serum Viscometers Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. RheoSense Whole Blood, Plasma and Serum Viscometers Product Portfolio Table 103. RheoSense Recent Development Table 104. Thermo Fisher Scientific Company Information Table 105. Thermo Fisher Scientific Business Overview Table 106. Thermo Fisher Scientific Whole Blood, Plasma and Serum Viscometers Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. Thermo Fisher Scientific Whole Blood, Plasma and Serum Viscometers Product Portfolio Table 108. Thermo Fisher Scientific Recent Development Table 109. Key Raw Materials Table 110. Raw Materials Key Suppliers Table 111. Whole Blood, Plasma and Serum Viscometers Distributors List Table 112. Whole Blood, Plasma and Serum Viscometers Customers List Table 113. Research Programs/Design for This Report Table 114. Authors List of This Report Table 115. Secondary Sources Table 116. Primary Sources List of Figures Figure 1. Whole Blood, Plasma and Serum Viscometers Product Image Figure 2. Global Whole Blood, Plasma and Serum Viscometers Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Whole Blood, Plasma and Serum Viscometers Sales Value (2021-2032) & (US$ Million) Figure 4. Global Whole Blood, Plasma and Serum Viscometers Sales (2021-2032) & (k units) Figure 5. Global Whole Blood, Plasma and Serum Viscometers Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global Whole Blood, Plasma and Serum Viscometers Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Rotational Viscometer Image Figure 10. Capillary Viscometer Image Figure 11. Global Whole Blood, Plasma and Serum Viscometers Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Whole Blood, Plasma and Serum Viscometers Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Whole Blood, Plasma and Serum Viscometers Sales Volume Share by Type (2021-2032) Figure 14. Global Whole Blood, Plasma and Serum Viscometers Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Whole Blood, Plasma and Serum Viscometers Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Whole Blood, Plasma and Serum Viscometers Sales Value Share by Type (2021-2032) Figure 17. Clinic Image Figure 18. Hospital Image Figure 19. Laboratory Image Figure 20. Global Whole Blood, Plasma and Serum Viscometers Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Whole Blood, Plasma and Serum Viscometers Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Whole Blood, Plasma and Serum Viscometers Sales Volume Share by Application (2021-2032) Figure 23. Global Whole Blood, Plasma and Serum Viscometers Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Whole Blood, Plasma and Serum Viscometers Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Whole Blood, Plasma and Serum Viscometers Sales Value Share by Application (2021-2032) Figure 26. Global Whole Blood, Plasma and Serum Viscometers Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 27. Global Whole Blood, Plasma and Serum Viscometers Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Whole Blood, Plasma and Serum Viscometers Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Whole Blood, Plasma and Serum Viscometers Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Whole Blood, Plasma and Serum Viscometers Sales Value (2021-2032) & (US$ Million) Figure 31. North America Whole Blood, Plasma and Serum Viscometers Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Whole Blood, Plasma and Serum Viscometers Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Whole Blood, Plasma and Serum Viscometers Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Whole Blood, Plasma and Serum Viscometers Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Whole Blood, Plasma and Serum Viscometers Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Whole Blood, Plasma and Serum Viscometers Sales Value (2021-2032) & (US$ Million) Figure 37. South America Whole Blood, Plasma and Serum Viscometers Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Whole Blood, Plasma and Serum Viscometers Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Whole Blood, Plasma and Serum Viscometers Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Whole Blood, Plasma and Serum Viscometers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Whole Blood, Plasma and Serum Viscometers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Whole Blood, Plasma and Serum Viscometers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Whole Blood, Plasma and Serum Viscometers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Whole Blood, Plasma and Serum Viscometers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Whole Blood, Plasma and Serum Viscometers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Whole Blood, Plasma and Serum Viscometers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Whole Blood, Plasma and Serum Viscometers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Whole Blood, Plasma and Serum Viscometers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Whole Blood, Plasma and Serum Viscometers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Whole Blood, Plasma and Serum Viscometers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Whole Blood, Plasma and Serum Viscometers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Whole Blood, Plasma and Serum Viscometers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Whole Blood, Plasma and Serum Viscometers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Whole Blood, Plasma and Serum Viscometers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Whole Blood, Plasma and Serum Viscometers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Whole Blood, Plasma and Serum Viscometers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Whole Blood, Plasma and Serum Viscometers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Whole Blood, Plasma and Serum Viscometers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Whole Blood, Plasma and Serum Viscometers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Whole Blood, Plasma and Serum Viscometers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Whole Blood, Plasma and Serum Viscometers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Whole Blood, Plasma and Serum Viscometers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Whole Blood, Plasma and Serum Viscometers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Whole Blood, Plasma and Serum Viscometers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Whole Blood, Plasma and Serum Viscometers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Whole Blood, Plasma and Serum Viscometers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Whole Blood, Plasma and Serum Viscometers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Whole Blood, Plasma and Serum Viscometers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Whole Blood, Plasma and Serum Viscometers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Whole Blood, Plasma and Serum Viscometers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Whole Blood, Plasma and Serum Viscometers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Whole Blood, Plasma and Serum Viscometers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Whole Blood, Plasma and Serum Viscometers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Whole Blood, Plasma and Serum Viscometers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Whole Blood, Plasma and Serum Viscometers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Whole Blood, Plasma and Serum Viscometers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Whole Blood, Plasma and Serum Viscometers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Whole Blood, Plasma and Serum Viscometers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Whole Blood, Plasma and Serum Viscometers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Whole Blood, Plasma and Serum Viscometers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Whole Blood, Plasma and Serum Viscometers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Whole Blood, Plasma and Serum Viscometers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Whole Blood, Plasma and Serum Viscometers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Whole Blood, Plasma and Serum Viscometers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Whole Blood, Plasma and Serum Viscometers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Whole Blood, Plasma and Serum Viscometers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Whole Blood, Plasma and Serum Viscometers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Whole Blood, Plasma and Serum Viscometers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Whole Blood, Plasma and Serum Viscometers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Whole Blood, Plasma and Serum Viscometers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Whole Blood, Plasma and Serum Viscometers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Whole Blood, Plasma and Serum Viscometers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Whole Blood, Plasma and Serum Viscometers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Whole Blood, Plasma and Serum Viscometers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Whole Blood, Plasma and Serum Viscometers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Whole Blood, Plasma and Serum Viscometers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Whole Blood, Plasma and Serum Viscometers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Whole Blood, Plasma and Serum Viscometers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Whole Blood, Plasma and Serum Viscometers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Whole Blood, Plasma and Serum Viscometers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Whole Blood, Plasma and Serum Viscometers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Whole Blood, Plasma and Serum Viscometers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Whole Blood, Plasma and Serum Viscometers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Whole Blood, Plasma and Serum Viscometers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Whole Blood, Plasma and Serum Viscometers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Whole Blood, Plasma and Serum Viscometers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Whole Blood, Plasma and Serum Viscometers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Whole Blood, Plasma and Serum Viscometers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Whole Blood, Plasma and Serum Viscometers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Whole Blood, Plasma and Serum Viscometers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Whole Blood, Plasma and Serum Viscometers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Whole Blood, Plasma and Serum Viscometers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Whole Blood, Plasma and Serum Viscometers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Whole Blood, Plasma and Serum Viscometers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Whole Blood, Plasma and Serum Viscometers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Whole Blood, Plasma and Serum Viscometers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Whole Blood, Plasma and Serum Viscometers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Whole Blood, Plasma and Serum Viscometers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Whole Blood, Plasma and Serum Viscometers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Whole Blood, Plasma and Serum Viscometers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Whole Blood, Plasma and Serum Viscometers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Whole Blood, Plasma and Serum Viscometers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Whole Blood, Plasma and Serum Viscometers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Whole Blood, Plasma and Serum Viscometers Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Whole Blood, Plasma and Serum Viscometers Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Rotational Viscometer
  • Capillary Viscometer
Applications
  • Clinic
  • Hospital
  • Laboratory
Companies covered
  • ​BioFluid Technology
  • AMETEK Brookfield
  • Anton Paar
  • Benson Viscometers
  • Health Onvector
  • LAMY RHEOLOGY
  • LAUDA
  • RheoSense
  • Thermo Fisher Scientific

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Whole Blood, Plasma and Serum Viscometers Sales Value (2021-2032)
  4. 1.2.2 Global Whole Blood, Plasma and Serum Viscometers Sales Volume (2021-2032)
  5. 1.2.3 Global Whole Blood, Plasma and Serum Viscometers Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Whole Blood, Plasma and Serum Viscometers Market Dynamics
  1. 2.1 Whole Blood, Plasma and Serum Viscometers Industry Trends
  2. 2.2 Whole Blood, Plasma and Serum Viscometers Industry Drivers
  3. 2.3 Whole Blood, Plasma and Serum Viscometers Industry Opportunities and Challenges
  4. 2.4 Whole Blood, Plasma and Serum Viscometers Industry Restraints
3 Whole Blood, Plasma and Serum Viscometers Market by Company
  1. 3.1 Global Whole Blood, Plasma and Serum Viscometers Company Revenue Ranking in 2025
  2. 3.2 Global Whole Blood, Plasma and Serum Viscometers Revenue by Company (2021-2026)
  3. 3.3 Global Whole Blood, Plasma and Serum Viscometers Sales Volume by Company (2021-2026)
  4. 3.4 Global Whole Blood, Plasma and Serum Viscometers Average Price by Company (2021-2026)
  5. 3.5 Global Whole Blood, Plasma and Serum Viscometers Company Ranking (2024-2026)
  6. 3.6 Global Whole Blood, Plasma and Serum Viscometers Company Manufacturing Base and Headquarters
  7. 3.7 Global Whole Blood, Plasma and Serum Viscometers Company Product Type and Application
  8. 3.8 Global Whole Blood, Plasma and Serum Viscometers Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Whole Blood, Plasma and Serum Viscometers Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Whole Blood, Plasma and Serum Viscometers Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Whole Blood, Plasma and Serum Viscometers Market by Type
  1. 4.1 Whole Blood, Plasma and Serum Viscometers Type Introduction
  2. 4.1.1 Rotational Viscometer
  3. 4.1.2 Capillary Viscometer
  4. 4.2 Global Whole Blood, Plasma and Serum Viscometers Sales Volume by Type
  5. 4.2.1 Global Whole Blood, Plasma and Serum Viscometers Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Whole Blood, Plasma and Serum Viscometers Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Whole Blood, Plasma and Serum Viscometers Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Whole Blood, Plasma and Serum Viscometers Sales Value by Type
  9. 4.3.1 Global Whole Blood, Plasma and Serum Viscometers Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Whole Blood, Plasma and Serum Viscometers Sales Value by Type (2021-2032)
  11. 4.3.3 Global Whole Blood, Plasma and Serum Viscometers Sales Value Share by Type (2021-2032)
5 Whole Blood, Plasma and Serum Viscometers Market by Application
  1. 5.1 Whole Blood, Plasma and Serum Viscometers Application Introduction
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Laboratory
  5. 5.2 Global Whole Blood, Plasma and Serum Viscometers Sales Volume by Application
  6. 5.2.1 Global Whole Blood, Plasma and Serum Viscometers Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Whole Blood, Plasma and Serum Viscometers Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Whole Blood, Plasma and Serum Viscometers Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Whole Blood, Plasma and Serum Viscometers Sales Value by Application
  10. 5.3.1 Global Whole Blood, Plasma and Serum Viscometers Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Whole Blood, Plasma and Serum Viscometers Sales Value by Application (2021-2032)
  12. 5.3.3 Global Whole Blood, Plasma and Serum Viscometers Sales Value Share by Application (2021-2032)
6 Whole Blood, Plasma and Serum Viscometers Regional Sales and Value Analysis
  1. 6.1 Global Whole Blood, Plasma and Serum Viscometers Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Whole Blood, Plasma and Serum Viscometers Sales by Region (2021-2032)
  3. 6.2.1 Global Whole Blood, Plasma and Serum Viscometers Sales by Region: 2021-2026
  4. 6.2.2 Global Whole Blood, Plasma and Serum Viscometers Sales by Region (2027-2032)
  5. 6.3 Global Whole Blood, Plasma and Serum Viscometers Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Whole Blood, Plasma and Serum Viscometers Sales Value by Region (2021-2032)
  7. 6.4.1 Global Whole Blood, Plasma and Serum Viscometers Sales Value by Region: 2021-2026
  8. 6.4.2 Global Whole Blood, Plasma and Serum Viscometers Sales Value by Region (2027-2032)
  9. 6.5 Global Whole Blood, Plasma and Serum Viscometers Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Whole Blood, Plasma and Serum Viscometers Sales Value (2021-2032)
  12. 6.6.2 North America Whole Blood, Plasma and Serum Viscometers Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Whole Blood, Plasma and Serum Viscometers Sales Value (2021-2032)
  15. 6.7.2 Europe Whole Blood, Plasma and Serum Viscometers Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Whole Blood, Plasma and Serum Viscometers Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Whole Blood, Plasma and Serum Viscometers Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Whole Blood, Plasma and Serum Viscometers Sales Value (2021-2032)
  21. 6.9.2 South America Whole Blood, Plasma and Serum Viscometers Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Whole Blood, Plasma and Serum Viscometers Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Whole Blood, Plasma and Serum Viscometers Sales Value Share by Country, 2025 VS 2032
7 Whole Blood, Plasma and Serum Viscometers Country-level Sales and Value Analysis
  1. 7.1 Global Whole Blood, Plasma and Serum Viscometers Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Whole Blood, Plasma and Serum Viscometers Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Whole Blood, Plasma and Serum Viscometers Sales by Country (2021-2032)
  4. 7.3.1 Global Whole Blood, Plasma and Serum Viscometers Sales by Country (2021-2026)
  5. 7.3.2 Global Whole Blood, Plasma and Serum Viscometers Sales by Country (2027-2032)
  6. 7.4 Global Whole Blood, Plasma and Serum Viscometers Sales Value by Country (2021-2032)
  7. 7.4.1 Global Whole Blood, Plasma and Serum Viscometers Sales Value by Country (2021-2026)
  8. 7.4.2 Global Whole Blood, Plasma and Serum Viscometers Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Whole Blood, Plasma and Serum Viscometers Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Whole Blood, Plasma and Serum Viscometers Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Whole Blood, Plasma and Serum Viscometers Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Whole Blood, Plasma and Serum Viscometers Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Whole Blood, Plasma and Serum Viscometers Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Whole Blood, Plasma and Serum Viscometers Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Whole Blood, Plasma and Serum Viscometers Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Whole Blood, Plasma and Serum Viscometers Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Whole Blood, Plasma and Serum Viscometers Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Whole Blood, Plasma and Serum Viscometers Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Whole Blood, Plasma and Serum Viscometers Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Whole Blood, Plasma and Serum Viscometers Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Whole Blood, Plasma and Serum Viscometers Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Whole Blood, Plasma and Serum Viscometers Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Whole Blood, Plasma and Serum Viscometers Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Whole Blood, Plasma and Serum Viscometers Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Whole Blood, Plasma and Serum Viscometers Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Whole Blood, Plasma and Serum Viscometers Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Whole Blood, Plasma and Serum Viscometers Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Whole Blood, Plasma and Serum Viscometers Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Whole Blood, Plasma and Serum Viscometers Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Whole Blood, Plasma and Serum Viscometers Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Whole Blood, Plasma and Serum Viscometers Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Whole Blood, Plasma and Serum Viscometers Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Whole Blood, Plasma and Serum Viscometers Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Whole Blood, Plasma and Serum Viscometers Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Whole Blood, Plasma and Serum Viscometers Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Whole Blood, Plasma and Serum Viscometers Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Whole Blood, Plasma and Serum Viscometers Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Whole Blood, Plasma and Serum Viscometers Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Whole Blood, Plasma and Serum Viscometers Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Whole Blood, Plasma and Serum Viscometers Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Whole Blood, Plasma and Serum Viscometers Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Whole Blood, Plasma and Serum Viscometers Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Whole Blood, Plasma and Serum Viscometers Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Whole Blood, Plasma and Serum Viscometers Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Whole Blood, Plasma and Serum Viscometers Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Whole Blood, Plasma and Serum Viscometers Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Whole Blood, Plasma and Serum Viscometers Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Whole Blood, Plasma and Serum Viscometers Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Whole Blood, Plasma and Serum Viscometers Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Whole Blood, Plasma and Serum Viscometers Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Whole Blood, Plasma and Serum Viscometers Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Whole Blood, Plasma and Serum Viscometers Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Whole Blood, Plasma and Serum Viscometers Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Whole Blood, Plasma and Serum Viscometers Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Whole Blood, Plasma and Serum Viscometers Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Whole Blood, Plasma and Serum Viscometers Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Whole Blood, Plasma and Serum Viscometers Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Whole Blood, Plasma and Serum Viscometers Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Whole Blood, Plasma and Serum Viscometers Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Whole Blood, Plasma and Serum Viscometers Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Whole Blood, Plasma and Serum Viscometers Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Whole Blood, Plasma and Serum Viscometers Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Whole Blood, Plasma and Serum Viscometers Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Whole Blood, Plasma and Serum Viscometers Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Whole Blood, Plasma and Serum Viscometers Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Whole Blood, Plasma and Serum Viscometers Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Whole Blood, Plasma and Serum Viscometers Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Whole Blood, Plasma and Serum Viscometers Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Whole Blood, Plasma and Serum Viscometers Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Whole Blood, Plasma and Serum Viscometers Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Whole Blood, Plasma and Serum Viscometers Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Whole Blood, Plasma and Serum Viscometers Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Whole Blood, Plasma and Serum Viscometers Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Whole Blood, Plasma and Serum Viscometers Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Whole Blood, Plasma and Serum Viscometers Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Whole Blood, Plasma and Serum Viscometers Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Whole Blood, Plasma and Serum Viscometers Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Whole Blood, Plasma and Serum Viscometers Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Whole Blood, Plasma and Serum Viscometers Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Whole Blood, Plasma and Serum Viscometers Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Whole Blood, Plasma and Serum Viscometers Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Whole Blood, Plasma and Serum Viscometers Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Whole Blood, Plasma and Serum Viscometers Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Whole Blood, Plasma and Serum Viscometers Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Whole Blood, Plasma and Serum Viscometers Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Whole Blood, Plasma and Serum Viscometers Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Whole Blood, Plasma and Serum Viscometers Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Whole Blood, Plasma and Serum Viscometers Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Whole Blood, Plasma and Serum Viscometers Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Whole Blood, Plasma and Serum Viscometers Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Whole Blood, Plasma and Serum Viscometers Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Whole Blood, Plasma and Serum Viscometers Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 ​BioFluid Technology
  2. 8.1.1 ​BioFluid Technology Company Information
  3. 8.1.2 ​BioFluid Technology Business Overview
  4. 8.1.3 ​BioFluid Technology Whole Blood, Plasma and Serum Viscometers Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 ​BioFluid Technology Whole Blood, Plasma and Serum Viscometers Product Portfolio
  6. 8.1.5 ​BioFluid Technology Recent Developments
  7. 8.2 AMETEK Brookfield
  8. 8.2.1 AMETEK Brookfield Company Information
  9. 8.2.2 AMETEK Brookfield Business Overview
  10. 8.2.3 AMETEK Brookfield Whole Blood, Plasma and Serum Viscometers Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 AMETEK Brookfield Whole Blood, Plasma and Serum Viscometers Product Portfolio
  12. 8.2.5 AMETEK Brookfield Recent Developments
  13. 8.3 Anton Paar
  14. 8.3.1 Anton Paar Company Information
  15. 8.3.2 Anton Paar Business Overview
  16. 8.3.3 Anton Paar Whole Blood, Plasma and Serum Viscometers Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Anton Paar Whole Blood, Plasma and Serum Viscometers Product Portfolio
  18. 8.3.5 Anton Paar Recent Developments
  19. 8.4 Benson Viscometers
  20. 8.4.1 Benson Viscometers Company Information
  21. 8.4.2 Benson Viscometers Business Overview
  22. 8.4.3 Benson Viscometers Whole Blood, Plasma and Serum Viscometers Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Benson Viscometers Whole Blood, Plasma and Serum Viscometers Product Portfolio
  24. 8.4.5 Benson Viscometers Recent Developments
  25. 8.5 Health Onvector
  26. 8.5.1 Health Onvector Company Information
  27. 8.5.2 Health Onvector Business Overview
  28. 8.5.3 Health Onvector Whole Blood, Plasma and Serum Viscometers Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Health Onvector Whole Blood, Plasma and Serum Viscometers Product Portfolio
  30. 8.5.5 Health Onvector Recent Developments
  31. 8.6 LAMY RHEOLOGY
  32. 8.6.1 LAMY RHEOLOGY Company Information
  33. 8.6.2 LAMY RHEOLOGY Business Overview
  34. 8.6.3 LAMY RHEOLOGY Whole Blood, Plasma and Serum Viscometers Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 LAMY RHEOLOGY Whole Blood, Plasma and Serum Viscometers Product Portfolio
  36. 8.6.5 LAMY RHEOLOGY Recent Developments
  37. 8.7 LAUDA
  38. 8.7.1 LAUDA Company Information
  39. 8.7.2 LAUDA Business Overview
  40. 8.7.3 LAUDA Whole Blood, Plasma and Serum Viscometers Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 LAUDA Whole Blood, Plasma and Serum Viscometers Product Portfolio
  42. 8.7.5 LAUDA Recent Developments
  43. 8.8 RheoSense
  44. 8.8.1 RheoSense Company Information
  45. 8.8.2 RheoSense Business Overview
  46. 8.8.3 RheoSense Whole Blood, Plasma and Serum Viscometers Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 RheoSense Whole Blood, Plasma and Serum Viscometers Product Portfolio
  48. 8.8.5 RheoSense Recent Developments
  49. 8.9 Thermo Fisher Scientific
  50. 8.9.1 Thermo Fisher Scientific Company Information
  51. 8.9.2 Thermo Fisher Scientific Business Overview
  52. 8.9.3 Thermo Fisher Scientific Whole Blood, Plasma and Serum Viscometers Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Thermo Fisher Scientific Whole Blood, Plasma and Serum Viscometers Product Portfolio
  54. 8.9.5 Thermo Fisher Scientific Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Whole Blood, Plasma and Serum Viscometers Value Chain Analysis
  2. 9.1.1 Whole Blood, Plasma and Serum Viscometers Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Whole Blood, Plasma and Serum Viscometers Sales Mode & Process
  6. 9.2 Whole Blood, Plasma and Serum Viscometers Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Whole Blood, Plasma and Serum Viscometers Distributors
  9. 9.2.3 Whole Blood, Plasma and Serum Viscometers Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst